Efficacy and Safety Study of Udenafil to Treat Erectile Dysfunction

Phase 3 Study to Evaluate the Efficacy and Safety of Once-a-day Dosing of Udenafil in the Treatment of Erectile Dysfunction

Study Design : multi-center, double-blind, placebo-controlled, randomized,

parallel group, fixed dose design

Phase : Phase III

Inclusion Criteria:

• Male patients aged 20 years or more diagnosed with ED

Exclusion Criteria:

• Had uncontrolled blood pressure
• Had hepatic or renal dysfunction
• Was currently under anticancer chemotherapy
• Had a treatments for ED using other PDE-5 inhibitors